Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 2, 2012, Pages 482-488

  Waser, Beatrice ^a   Rehmann, Ruth ^a   Sanchez, Claire ^b   Fourmy, Daniel ^b   Reubi, Jean Claude ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR; HORMONE RECEPTOR; MESSENGER RNA; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; BRONCHUS TUMOR; CONTROLLED STUDY; GASTROINTESTINAL TUMOR; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; NEUROENDOCRINE TUMOR; PANCREAS ISLET; PANCREAS TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECEPTOR BINDING; TISSUE DISTRIBUTION;

BRONCHIAL NEOPLASMS; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IODINE RADIOISOTOPES; NEUROENDOCRINE TUMORS; OSMOLAR CONCENTRATION; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, GLUCAGON; TISSUE DISTRIBUTION;

EID: 84856776511     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2454     Document Type: Article

References (26)

1. Oberg KE, Reubi JC, Kwekkeboom DJ, Krenning EP 2010 Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy. Gastroenterology 139:742-753, 753e1
2. Christ E, Wild D, Forrer F, Brändle M, Sahli R, Clerici T, Gloor B, Martius F, Maecke H, Reubi JC 2009 Glucagon-like peptide-1 receptor imaging for localization of insulinomas. J Clin Endocrinol Metab 94:4398-4405
3. Wild D, Mäcke H, Christ E, Gloor B, Reubi JC 2008 Glucagon-like peptide 1-receptor scans to localize occult insulinomas. N Engl J Med 359:766-768
4. Reubi JC 2003 Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 24:389-427 (Pubitemid 37056239)
5. Reubi JC, Waser B 2003 Concomitant expression of several peptide receptors in neuroendocrine tumors as molecular basis for in vivo multireceptor tumor targeting. Eur J Nucl Med Mol Imaging 30: 781-793 (Pubitemid 36612963)
6. Mayo KE, Miller LJ, Bataille D, Dalle S, Göke B, Thorens B, Drucker DJ 2003 International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev 55:167-194 (Pubitemid 36268402)
7. McIntosh CH, Widenmaier S, Kim SJ 2009 Glucose-dependent insulinotropic polypeptide (gastric inhibitory polypeptide; GIP). Vitam Horm 80:409-471
8. Asmar M, Holst JJ 2010 Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances. Curr Opin Endocrinol Diabetes Obes 17:57-62
9. Holst JJ, Vilsbøll T, Deacon CF 2009 The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol 297:127-136
10. Ahrén B 2009 Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov 8:369-385
11. Knop FK, Vilsbøll T, Holst JJ 2009 Incretin-based therapy of type 2 diabetes mellitus. Curr Protein Pept Sci 10:46-55
12. Tharakan G, Tan T, Bloom S 2011 Emerging therapies in the treatment of 'diabesity': beyond GLP-1. Trends Pharmacol Sci 32:8-15
13. Yip RG, Wolfe MM 2000 GIP biology and fat metabolism. Life Sci 66:91-103 (Pubitemid 30025456)
14. Nyberg J, Jacobsson C, Anderson MF, Eriksson PS 2007 Immunohistochemical distribution of glucose-dependent insulinotropic polypeptide in the adult rat brain. J Neurosci Res 85:2099-2119 (Pubitemid 47172142)
15. Usdin TB, Mezey E, Button DC, Brownstein MJ, Bonner TI 1993 Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133:2861-2870 (Pubitemid 24000747)
16. Körner M, Hayes GM, Rehmann R, Zimmermann A, Scholz A, Wiedenmann B, Miller LJ, Reubi JC 2006 Secretin receptors in the human liver: Expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma. J Hepatol 45: 825-835 (Pubitemid 44646678)
17. Reubi JC, Körner M, Waser B, Mazzucchelli L, Guillou L 2004 High expression of peptide receptors as a novel target in gastrointestinal stromal tumours. Eur J Nucl Med Mol Imaging 31:803-810 (Pubitemid 38758349)
18. Reubi JC, Läderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA 2000 Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Cancer Res 60:3105-3112 (Pubitemid 30395841)
19. Reubi JC, Kvols LK, Waser B, Nagorney DM, Heitz PU, Charboneau JW, Reading CC, Moertel C 1990 Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 50:5969-5977 (Pubitemid 20331408)
20. Körner M, Stöckli M, Waser B, Reubi JC 2007 GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med 48:736-743 (Pubitemid 47604973)
21. Yaqub T, Tikhonova IG, Lättig J, Magnan R, Laval M, Escrieut C, Boulègue C, Hewage C, Fourmy D 2010 Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand. Mol Pharmacol 77:547-558
22. Wild D, Christ E, Caplin ME, Kurzawinski TR, Forrer F, Brändle M, Seufert J, Weber WA, Bomanji J, Perren A, Ell PJ, Reubi JC 2011 Glucagon-like peptide-1 vs. somatostatin receptor targeting in malignant insulinomas. J Nucl Med 52:1073-1078
23. Brom M, Andrałojæ K, Oyen WJ, Boerman OC, Gotthardt M 2010 Development of radiotracers for the determination of the β-cell mass in vivo. Curr Pharm Des 16:1561-1567
24. Wu Z, Kandeel F 2010 Radionuclide probes for molecular imaging of pancreatic β-cells. Adv Drug Deliv Rev 62:1125-1138
25. Holst JJ, Knop FK, Vilsboll T, Krarup T, Madsbad S 2011 Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes. Diabetes Care 34(Suppl 2):S251-S257
26. Reubi JC, Maecke HR 2008 Peptide-based probes for cancer imaging. J Nucl Med 49:1735-1738